Liraglutide 1.8 mg treatment aims to prevent Type 2 Diabetes in obese women post-gestational diabetes
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
Abstract
A 5-year randomized, placebo-controlled trial investigates if liraglutide 1.8 mg daily can reduce Type 2 Diabetes risk in obese women with prior gestational diabetes.